Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
about
Myeloid-Derived Suppressor Cells in Bacterial InfectionsCurrent status of immunotherapyThe potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapySignaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated MacrophagesMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentDendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancerHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerControl of the immune response by pro-angiogenic factorsMultimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapyMyeloid-derived cells are key targets of tumor immunotherapyModification of the tumor microenvironment as a novel target of renal cell carcinoma therapeuticsCoordinated regulation of myeloid cells by tumoursThe anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer modelProdrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor SunitinibSTATs in cancer inflammation and immunity: a leading role for STAT3Reduced immunosuppressive properties of axitinib in comparison with other tyrosine kinase inhibitors.Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkersStructurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity.Signal integration and gene induction by a functionally distinct STAT3 phosphoform.Extracerebral metastases determine the outcome of patients with brain metastases from renal cell carcinoma.Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinaseAnti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3)Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.Interleukin-6 in bone metastasis and cancer progression.Targeting immune suppressing myeloid-derived suppressor cells in oncology.STAT3 activation in monocytes accelerates liver cancer progression.Granulocyte macrophage colony-stimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy.Intravital imaging of anti-tumor immune response and the tumor microenvironment.The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA.Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Deciphering the anticancer mechanisms of sunitinib.MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma.
P2860
Q26749373-8FDE3C14-6497-41C5-94E9-511615092D4CQ26773314-0E7B35A6-BE02-413F-B7B0-1FC43A0B637FQ26783291-629D9996-3C5F-4489-B615-7464D9F412CDQ26783748-9AF11EC4-CA39-45A4-9FDA-C362FBE778DCQ26799126-E489ABA3-7296-41FC-B149-343A2BCB7DAEQ26861293-DA571A47-14BE-453B-BC45-2297583FECCBQ26863418-E23620D9-D19F-4E0D-82A7-895B686E589FQ27004733-FB20F9F7-EF3F-4CEE-A583-196ED8DC51BFQ28077050-AC71CAFA-E33B-42F6-ACAA-FFD39CDBFD40Q28388246-CB9D8E0E-6F04-401E-8E86-6A522EB60E0EQ28393614-22FF7519-169B-4EE2-ACEE-34680977FB8EQ28395157-179B26B9-0834-4476-8E56-86E3F28D77C0Q28538542-05B71B3E-9B9B-4D6A-B66A-0F7F9558B677Q28550556-0FD57AF5-B177-43B1-B196-7046AB6B15C8Q29547203-701E3084-8431-4802-B7D8-A264B1AAE8DDQ30317831-E111DC97-3792-4BBE-9CBF-72A0717DEB0EQ30411008-89F62947-35D0-433D-A254-0F3142D9D106Q30472042-D4863C24-5005-4D9E-B67A-92329F995BADQ31085777-A79436EB-E321-4ECF-8421-410710EAE546Q33598739-5902AE92-30DC-47D6-A502-E4A976544071Q33602531-A8A2B10E-7920-4569-A3DA-163D8E875F9AQ33685045-5C588E1B-9EDD-4DA5-B6C7-BAEACD2CBCCDQ33703886-FDF7C9C8-2530-4925-9751-44D9D766D4C0Q33733198-21EB1F11-E0B6-4256-903C-8C622F50B116Q33889920-17A278B9-352E-4E54-BBF1-5EE6B5A36AE2Q33936548-820A3742-BBE9-4FEB-BB8B-A0AC27DC178EQ34051820-7822B9AC-9AC1-4DF0-9E91-06C662EE34DBQ34082067-0CD947CC-BADD-434D-96DD-4B2A0FA27B63Q34089708-8C0A1E32-48EF-4233-842A-55AD41281EF1Q34265694-0E289FEE-5E51-45B6-88B8-DAE8DE724817Q34271815-31F87213-A53A-466A-AD95-CF57F648A8B1Q34389359-CDB0C46E-03E5-457F-B98A-218D471A3801Q34473451-0A27A8A3-ECC5-41AA-A186-FE16DD67325FQ34681856-3975C4EB-0109-41B2-882A-4367AD80B3DFQ34940989-F19DD705-238E-4344-A095-CC632B8D0F15Q34978840-324C745B-4DB7-421F-8E68-FAF6FD8C7CDAQ35028389-C2AFD263-3705-4DA0-BE70-BFF843285F68Q35033957-CF21B10A-2796-4E90-A690-FF4453B3368DQ35064011-CC0B93B8-4636-4186-BB04-4C7668FD9400Q35093466-B3A96751-1E97-4F0D-BAC7-83345CB35005
P2860
Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@en
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@nl
type
label
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@en
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@nl
prefLabel
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@en
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@nl
P2093
P2860
P1433
P1476
Sunitinib inhibition of Stat3 ...... duces immunosuppressive cells.
@en
P2093
Andreas Herrmann
Chunyan Zhang
Robert Figlin
P2860
P304
P356
10.1158/0008-5472.CAN-08-4323
P407
P577
2009-02-24T00:00:00Z